Target intelligence / Profile preview

Cyclin D2 mRNA 3' untranslated region (CCND2 mRNA 3' UTR)

Target
CCND2 mRNA 3' UTR
Molecular classification
RNA, mRNA, Untranslated region
01

Overview

The Cyclin D2 (CCND2) mRNA 3' untranslated region (UTR) is a key regulatory element of the CCND2 gene transcript, playing a pivotal role in controlling protein expression levels through post-transcriptional mechanisms (Source: NIH/PubMed). CCND2 itself is a critical regulator of the G1/S phase transition in the cell cycle, and its precise control is essential for normal cellular proliferation (Source: UniProt P30279). The 3' UTR serves as a scaffold for the binding of microRNAs (miRNAs) and RNA-binding proteins that influence mRNA stability and translation efficiency (Source: Frontiers in Oncology). In various cancers, including mantle cell lymphoma and leukemia, the CCND2 3' UTR is frequently altered or its regulatory miRNA interactions are disrupted, leading to pathological overexpression of the Cyclin D2 protein (Source: NIH/PubMed). This makes the 3' UTR a significant target for emerging RNA-targeted therapies, such as antisense oligonucleotides (ASOs) and miRNA mimics, which aim to downregulate CCND2 expression (Source: CAS.org). Additionally, germline mutations in CCND2 or its regulatory pathways are associated with Megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndrome, highlighting its importance in developmental biology (Source: Nature Genetics). Targeting this region offers a strategy to selectively modulate the cell cycle in hyperproliferative diseases.

Other names
CCND2 3' UTRCyclin D2 3' UTRCCND2 three prime untranslated region
02

Mechanism of action

RNA interference and antisense-mediated degradation or translational inhibition

03

Biological functions

Cell cycle regulationmRNA stability regulationTranslation regulationG1/S transition
04

Disease associations

CancerB-cell lymphomaMantle cell lymphomaMegalencephaly-polymicrogyria-polydactyly-hydrocephalus syndromeEndometrial cancer
05

Safety considerations

Off-target hybridizationSystemic delivery challengesPotential for innate immune response to synthetic RNA
06

Interacting drugs

miR-26a mimics (experimental)

2 more in the full profile.

07

Biomarkers

CCND2 mRNA expressionCCND2 protein levelsmiR-26a levels3' UTR length (Alternative Polyadenylation status)

Beyond the preview

Go deeper on Cyclin D2 mRNA 3' untranslated region (CCND2 mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin D2 mRNA 3' untranslated region (CCND2 mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call